TNF-α inhibitors have been shown to reduce systemic inflammation in autoimmune diseases, and their potential role in modulating T-helper cell differentiation in metabolic disorders warrants further investigation (62, 63). The gene discussed is TNF; the disease is Other metabolic disease.